terfenadine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 2 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is no established treatment for chronic fatigue syndrome (CFS), an illness characterized by disabling fatigue exacerbated by physical activity." | 2.68 | Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. ( Lurie, N; Marshall, P; McNutt, BE; Peterson, PK; Pheley, A; Schenck, C; Steinberg, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinberg, P | 2 |
| McNutt, BE | 1 |
| Marshall, P | 1 |
| Schenck, C | 1 |
| Lurie, N | 1 |
| Pheley, A | 1 |
| Peterson, PK | 2 |
| Marshall, PS | 1 |
| Watson, D | 1 |
| Cornblatt, B | 1 |
| Callies, A | 1 |
| Schenck, CH | 1 |
2 trials available for terfenadine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.
Topics: Administration, Oral; Adult; Double-Blind Method; Fatigue Syndrome, Chronic; Female; Histamine H1 An | 1996 |
An assessment of cognitive function and mood in chronic fatigue syndrome.
Topics: Adult; Aged; Anti-Allergic Agents; Attention; Cognition Disorders; Depression; Double-Blind Method; | 1996 |